drugset / Trial / NCT01913808
Comparing Intravenous and Oral Iron in Postoperative Anemia
RandomizedParallel-groupSingle-blindTreatment
Summary
Postoperative anaemia are common in patients undergoing major orthopaedic surgery. The main consequence of perioperative anaemia is an increased risk of red blood cell (RBC) transfusions. Allogeneic RBC transfusion and anaemia are associated with higher postoperative mortality and morbidity. The aim of this study was to compare the efficacy of postoperative i.v. ferric carboxymaltose (FCM) and oral ferrous glycine sulphate (FS) for early improvement of postoperative anaemia after total knee arthroplasty and whether iron treatment could facilitate recovery from surgery.
Timeline
- Start
- 2011-01
- Primary completion
- 2012-02
- Completion
- 2013-01
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Ferric carboxymaltose | Other / unclassified | — | Intravenous |
| Comparator | Ferrous Glycine Sulfate | Unknown | 100 mg | Oral |